CAS
52232-67-4
AA-Sequence
H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
Originator
Sanofi-aventis
First marketed by
Eli Lilly
Name of FDF
Forteo®, Forsteo®
Original FDF
RTU solution for subcutaneous injection
Mode of Action
Bioactive portion of the parathyroid hormone. Effective anabolic (promoting bone formation). An effective anabolic (promoting bone formation) agent used in the treatment of osteoporosis (Endocrinology, Musculoskeletal).
Indications
Male osteoporosis; Osteoporosis; Postmenopausal osteoporosis
Patent status
Generic products are available